A tastier calcium chew might boost bone Health—But does it work?

NCT ID NCT07763509

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial tests whether a calcium-rich food chew, made from milk-derived minerals, is easier for women to take daily than a standard calcium carbonate pill. Women aged 40 to 90 at increased risk for osteoporosis will be randomly assigned to one of the two forms for four weeks. The study tracks how consistently they take it, any stomach issues, and overall satisfaction—without any blood draws or scans. The goal is to see if the form of calcium affects adherence and comfort, which could influence long-term bone health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A calcium-rich food chew providing 500 mg of calcium from milk-derived minerals, compared to a standard calcium carbonate supplement.
What this could lead to
If the chew is easier to stick with and gentler on the stomach, it could offer a more acceptable daily calcium option for women trying to protect their bones.
What could go wrong
This is a short, four-week study, so long-term bone benefits are not measured. Results may not apply to all women, and the chew could still cause digestive discomfort in some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE HEALTH IN PERIMENOPAUSAL WOMEN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bone Diseases, Metabolic bone fracture osteoporosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical and Translational Science Center, Weill Cornell Medical College

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.